R1 RCM Inc. (RCM)
USD 14.31
(0.0%)
USD 14.31
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.2 Billion USD | -8.7% |
| 2022 | 2.41 Billion USD | 119.42% |
| 2021 | 1.1 Billion USD | 29.78% |
| 2020 | 849.6 Million USD | -6.74% |
| 2019 | 911 Million USD | 13.7% |
| 2018 | 801.2 Million USD | 164.77% |
| 2017 | 302.6 Million USD | -29.2% |
| 2016 | 427.39 Million USD | -36.55% |
| 2015 | 673.6 Million USD | 14.44% |
| 2014 | 588.61 Million USD | -1.17% |
| 2013 | 595.6 Million USD | -24.95% |
| 2012 | 793.57 Million USD | 529.31% |
| 2011 | 126.1 Million USD | 5.17% |
| 2010 | 119.9 Million USD | 45.88% |
| 2009 | 82.19 Million USD | 4.07% |
| 2008 | 78.98 Million USD | 75.72% |
| 2007 | 44.94 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.95 Billion USD | -0.45% |
| 2024 Q1 | 2.97 Billion USD | 34.53% |
| 2024 Q3 | 2.93 Billion USD | -0.67% |
| 2023 Q3 | 2.29 Billion USD | -1.53% |
| 2023 FY | 2.2 Billion USD | -8.7% |
| 2023 Q4 | 2.2 Billion USD | -3.78% |
| 2023 Q1 | 2.35 Billion USD | -2.73% |
| 2023 Q2 | 2.33 Billion USD | -0.93% |
| 2022 Q2 | 2.33 Billion USD | 118.7% |
| 2022 FY | 2.41 Billion USD | 119.42% |
| 2022 Q1 | 1.06 Billion USD | -2.97% |
| 2022 Q4 | 2.41 Billion USD | 4.58% |
| 2022 Q3 | 2.31 Billion USD | -1.12% |
| 2021 FY | 1.1 Billion USD | 29.78% |
| 2021 Q4 | 1.1 Billion USD | -4.06% |
| 2021 Q3 | 1.14 Billion USD | 34.31% |
| 2021 Q2 | 855.7 Million USD | 0.56% |
| 2021 Q1 | 850.9 Million USD | 0.15% |
| 2020 Q2 | 1.09 Billion USD | 20.12% |
| 2020 FY | 849.6 Million USD | -6.74% |
| 2020 Q1 | 911.4 Million USD | 0.04% |
| 2020 Q3 | 1.14 Billion USD | 4.31% |
| 2020 Q4 | 849.6 Million USD | -25.6% |
| 2019 Q4 | 911 Million USD | 2.76% |
| 2019 Q1 | 904 Million USD | 12.83% |
| 2019 Q2 | 908.9 Million USD | 0.54% |
| 2019 FY | 911 Million USD | 13.7% |
| 2019 Q3 | 886.5 Million USD | -2.46% |
| 2018 Q4 | 801.2 Million USD | 5.76% |
| 2018 Q3 | 757.6 Million USD | 3.87% |
| 2018 Q1 | 319.7 Million USD | 5.65% |
| 2018 Q2 | 729.4 Million USD | 128.15% |
| 2018 FY | 801.2 Million USD | 164.77% |
| 2017 FY | 302.6 Million USD | -29.2% |
| 2017 Q4 | 302.6 Million USD | 8.26% |
| 2017 Q3 | 279.5 Million USD | 7.05% |
| 2017 Q2 | 261.1 Million USD | 0.62% |
| 2017 Q1 | 259.5 Million USD | -39.28% |
| 2016 Q2 | 550.45 Million USD | 0.6% |
| 2016 Q1 | 547.16 Million USD | -18.77% |
| 2016 Q3 | 475.18 Million USD | -13.67% |
| 2016 FY | 427.39 Million USD | -36.55% |
| 2016 Q4 | 427.39 Million USD | -10.06% |
| 2015 FY | 673.6 Million USD | 14.44% |
| 2015 Q4 | 673.6 Million USD | -5.72% |
| 2015 Q3 | 714.43 Million USD | 9.18% |
| 2015 Q2 | 654.34 Million USD | 5.98% |
| 2015 Q1 | 617.44 Million USD | 4.9% |
| 2014 Q3 | 615.71 Million USD | 1.94% |
| 2014 Q4 | 588.61 Million USD | -4.4% |
| 2014 FY | 588.61 Million USD | -1.17% |
| 2014 Q1 | 638.61 Million USD | 7.22% |
| 2014 Q2 | 603.98 Million USD | -5.42% |
| 2013 Q2 | 552 Million USD | -34.11% |
| 2013 Q1 | 837.7 Million USD | 5.56% |
| 2013 FY | 595.6 Million USD | -24.95% |
| 2013 Q4 | 595.6 Million USD | -3.64% |
| 2013 Q3 | 618.1 Million USD | 11.97% |
| 2012 Q2 | 161.7 Million USD | 5.67% |
| 2012 Q3 | 170.96 Million USD | 5.72% |
| 2012 Q1 | 153.02 Million USD | 21.35% |
| 2012 Q4 | 793.57 Million USD | 364.19% |
| 2012 FY | 793.57 Million USD | 529.31% |
| 2011 Q2 | 121.42 Million USD | 8.04% |
| 2011 Q3 | 139.06 Million USD | 14.53% |
| 2011 Q4 | 126.1 Million USD | -9.32% |
| 2011 Q1 | 112.38 Million USD | -6.27% |
| 2011 FY | 126.1 Million USD | 5.17% |
| 2010 Q4 | 119.9 Million USD | 20.57% |
| 2010 Q3 | 99.44 Million USD | 15.74% |
| 2010 Q2 | 85.91 Million USD | -1.79% |
| 2010 Q1 | 87.47 Million USD | 6.43% |
| 2010 FY | 119.9 Million USD | 45.88% |
| 2009 Q3 | 84.33 Million USD | -1.27% |
| 2009 Q2 | 85.42 Million USD | 0.0% |
| 2009 Q4 | 82.19 Million USD | -2.54% |
| 2009 FY | 82.19 Million USD | 4.07% |
| 2008 Q4 | 78.98 Million USD | 0.0% |
| 2008 FY | 78.98 Million USD | 75.72% |
| 2007 FY | 44.94 Million USD | 0.0% |
| 2000 Q4 | 2.41 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 1.26 Billion USD | -74.929% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 91.215% |
| Sharecare, Inc. | 125.56 Million USD | -1659.089% |
| Progyny, Inc. | 203.19 Million USD | -987.056% |
| Aclarion, Inc. | 3.18 Million USD | -69189.839% |
| CareMax, Inc. | 561.85 Million USD | -293.125% |
| Simulations Plus, Inc. | 14.2 Million USD | -15446.171% |
| CareCloud, Inc. | 37.79 Million USD | -5743.85% |
| Forian Inc. | 33.19 Million USD | -6553.74% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -1198055.682% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -1198055.682% |
| Minerva Surgical, Inc. | 51.71 Million USD | -4170.771% |
| Omnicell, Inc. | 1.03 Billion USD | -112.809% |
| Definitive Healthcare Corp. | 626.72 Million USD | -252.434% |
| Zhongchao Inc. | 3.37 Million USD | -65278.649% |
| Accolade, Inc. | 342.68 Million USD | -544.555% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | -9534.476% |
| Ontrak, Inc. | 5.57 Million USD | -39519.731% |
| SOPHiA GENETICS SA | 54.71 Million USD | -3936.992% |
| Spok Holdings, Inc. | 63.91 Million USD | -3355.948% |
| Privia Health Group, Inc. | 392.51 Million USD | -462.736% |
| EUDA Health Holdings Limited | 8.79 Million USD | -25021.57% |
| HeartBeam, Inc. | 1.19 Million USD | -184891.625% |
| GeneDx Holdings Corp. | 245.65 Million USD | -799.14% |
| TruBridge, Inc. | 247.8 Million USD | -791.35% |
| Nutex Health, Inc. | 319.13 Million USD | -592.111% |
| Renalytix Plc | 15.82 Million USD | -13856.78% |
| Sharecare, Inc. | 125.56 Million USD | -1659.089% |
| Health Catalyst, Inc. | 334.89 Million USD | -559.55% |
| 10x Genomics, Inc. | 224.1 Million USD | -885.631% |
| GoodRx Holdings, Inc. | 826.84 Million USD | -167.137% |
| SCWorx Corp. | 2.42 Million USD | -90993.326% |
| Schrödinger, Inc. | 254.39 Million USD | -768.249% |
| HealthEquity, Inc. | 1.2 Billion USD | -83.84% |
| HealthStream, Inc. | 159.19 Million USD | -1287.524% |
| MSP Recovery, Inc. | 1.74 Billion USD | -26.879% |
| Augmedix, Inc. | 43.39 Million USD | -4990.457% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 57.343% |
| Ontrak, Inc. | 5.57 Million USD | -39519.731% |
| SHL Telemedicine Ltd. | 36.58 Million USD | -5936.916% |
| CareCloud, Inc. | 37.79 Million USD | -5743.85% |
| Premier, Inc. | 1.46 Billion USD | -50.631% |
| Certara, Inc. | 516.29 Million USD | -327.813% |
| GeneDx Holdings Corp. | 245.65 Million USD | -799.14% |
| OneMedNet Corporation | 13.32 Million USD | -16479.268% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 57.343% |
| EUDA Health Holdings Limited | 8.79 Million USD | -25021.57% |
| HeartBeam, Inc. | 1.19 Million USD | -184891.625% |
| CareCloud, Inc. | 37.79 Million USD | -5743.85% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -800076.787% |
| CareMax, Inc. | 561.85 Million USD | -293.125% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -23123.636% |
| National Research Corporation | 73.48 Million USD | -2905.906% |
| Aclarion, Inc. | 3.18 Million USD | -69189.839% |
| OptimizeRx Corporation | 56.82 Million USD | -3787.314% |